Wednesday, 24 October 2018

Animal Pharmaceuticals Market Overview, Product, Animal Type, Growth and Demand Forecast to 2022


The global animal pharmaceuticals market was valued at $12,614.3 million in 2015, and it is expected to grow at a CAGR of 7.7% during 2016 - 2022. The growth of the global market is largely driven by increasing consumption of meat and milk, and increasing zoonotic and food borne diseases. Due to growing health concern of related animals and their increasing number, the healthcare expenses in farms are surging globally.



Among the different types of animal pharmaceutical products, the ectoparasiticides generated largest revenue in the global animal pharmaceuticals market in 2015. High prevalence of animals affected with ectoparasites is the key factor driving the growth of the ectoparasiticides market. The bronchodilators market would witness fastest growth during the forecast period.


Based on animal type, the largest revenue was generated from the sales of animal pharmaceuticals for companion animals in 2015. Whereas, the animal pharmaceuticals market for production animals would witness faster growth during the forecast period. Increasing awareness regarding the livestock related diseases is the key reason behind the higher growth of the animal pharmaceuticals market for production animals.

Some of the key players operating in the global market include Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc., Virbac SA, Boehringer Ingelheim GmbH, Perrigo Company plc, Eli Lilly and Company, Sanofi and Bayer AG.

Thursday, 9 August 2018

Disinfectors Market : Uncovers Potential Demands in the Market


Owing to the fact that cleaning and sanitation are vital for safety in the healthcare industries, the global market for disinfectants is driven by increased focus on hygiene and growing concerns over the spread of infectious diseases both at home and in public places. Rising demands in the food, beverage and healthcare industries is driving the global disinfectors market. Disinfectant chemicals are also becoming more common as an ingredient in various conventional and industrial cleaning products.


Disinfectors are used for destroying pathogens for controlling infection.
The global disinfectant market can be categorized on the basis of disinfectors by product type, and disinfectors by applications. Based on disinfectors by product type, the global market for disinfectors is divided into washer, flusher and endoscope reprocessor. The washer is further divided into a single chamber (single door and double door) and multi chamber. On the basis of application, the global disinfectors market is classified into elder care, hospitals and clinics, and pharmaceuticals and life sciences.
Increasing demand from hospitals to disinfect surfaces and patient rooms efficiently and effectively against a wide range of viruses and bacteria has driven manufacturers to create widely applicable disinfection products that work more quickly.  Surgeries require wide usage of various medical instruments such as forceps, scissors and complex surgical instruments that are in constant contact with the patient’s body. If these instruments are not disinfected properly, the patient is exposed to surgical site infections (SSI). Hence, the disinfectors market is expected to increase owing to the rising number of surgeries performed across the world.

One of the major challenges in disinfectors market is the growing trend of medical institutions and clinics to use disposable medical devices that do not need sterilization or disinfection.
Owing to the rise in number of chronic diseases, epidemic diseases such as H1N1 and aging population, North America dominates the disinfectors market followed by Europe.


Some of the major competitors in the global disinfectors market are Advanced Sterilization Products Division Ethicon US, LLC, Getinge AB, OLYMPUS CORPORATION and STERIS Corporation. Other prominent competitors in the market include ACTAVIS, American Biotech Labs, LLC, Amrep Inc, CareFusion Corporation, CCP Industries , Bio-Cide International, Inc., BIOTECHMEDICS US., Cantel Medical, Colgate-Palmolive Company., Swisher International, Inc., Diversey Inc.and many more.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook

Wednesday, 8 August 2018

North America Dominates the Global Blood Processing Devices and Consumables Market Followed by Europe


Increasing infections and related diseases due to blood transfusion and blood donation are some of the major concerns in healthcare arena. Infectious diseases through blood transfusions occur due to the presence of microorganism, such as bacteria, virus and others parasites, in blood of donors which reach to receivers and infect their blood.



Hepatitis and Acquired Immunodeficiency Syndrome (AIDS) are some of the major infectious diseases which pose great challenge to healthcare providers for the prevention and treatment of these diseases. To overcome this problem, various blood processing devices and blood processing consumables are used to prevent infection in blood transfusion and blood donation procedures.


Blood processing devices are used in cell processing, blood refrigeration and centrifugation of blood cells. Blood processing consumables are used in collection of blood and grouping by various reagents.

Blood processing consumables segment includes blood bags, blood administration sets, sedimentation tubes, blood collection tubes, blood collection needles, blood grouping reagents, coagulation reagents, vials, microscopic slides, hematology reagents, slide stainer, blood lancets, blood filters and test tube racks.

North America dominates the global blood processing devices and consumables market followed by Europe. This is due to increased awareness, developed economies and increased government support in the region. In addition, high disposable incomes and favorable reimbursement policies are also supporting in the growth of blood processing devices and consumables market in the region. 
Asia-Pacific represents the fastest growing region in the global blood processing devices and consumables market. Government initiatives and campaigns in countries, such as India and China, are trying to educate people about safe blood donations and transfusions procedures. This would develop opportunity for blood processing devices and consumable market in Asia.


Some of the major competitors in the market include Abbott Laboratories, Biomerieux SA, Becton, Dickinson And Company, Bio-Rad Laboratories, Danaher Corporation, Grifols International, Thermogenesis Corporation, Terumo Corporation, Roche Holdings AG, Macopharma SA, Immucor, Inc. and Haemonetics Corporation.

About P&S Intelligence


P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


Contact: 
P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455

Connect with us: LinkedIn | Twitter | Google + | Facebook

Thursday, 2 August 2018

Disposable Gloves Market | Emerging Industry with Medical and Non-Medical Segments

The global disposable gloves market is growing significantly due to increasing awareness about hand hygiene and patient safety among healthcare providers and patients, and high incidences of communicable diseases. Several government and non-governmental organizations are actively promoting and funding campaigns aimed at encouraging the use of disposable gloves in medical practices; hence, propelling the growth of global disposable gloves market.


Disposable gloves market can be categorized on the basis of products and applications. Based on products, the disposable gloves market can be categorized as natural rubber or latex gloves, neoprene gloves, vinyl gloves, nitrile gloves, and others. On the basis of applications, disposable gloves market can be segmented as medical and non-medical applications. The medical applications segment includes examination, surgery, and others. The non-medical applications segment includes food sector, cleanroom sector, and others.


Some of the factors driving the growth of the global disposable gloves market are increasing awareness about hand hygiene and patient safety among healthcare providers and patients, increasing incidences of infectious diseases, high healthcare expenditure, and increasing patient compliance for surgical treatment. However, low healthcare access in the remote areas of developing countries is the factor restraining the growth of the global disposable gloves market to some extent.

Geographically, North America will be leading the global disposable gloves market in the coming years due to high awareness regarding hand hygiene among patient and healthcare providers, high healthcare expenditure, high prevalence of infectious diseases, and high patient compliance for surgical treatment.

Asia-Pacific is the fastest growing region in the global disposable gloves market and the major reasons driving the growth are improving healthcare infrastructure, high prevalence of communicable-diseases, and increasing healthcare expenditure. Moreover, the disposable gloves market is growing rapidly due the increased government funding and increasing awareness about hand hygiene and patient safety among patients and care givers in emerging economies, such as India and China.

Some of the major players operating in the global disposable gloves market are Ansell Healthcare, Adventa Berhad, Cardinal Health Inc., Dynarex Corporation, Kossan Rubber Industries Bhd., Kimberley-Clark Corporation, Medisafe Technologies, Medline Industries Inc., Paul Hartmann AG, Top Glove Corporation Berhad, and Supermax Corporation Berhad.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Connect with us: LinkedIn | Twitter | Google + | Facebook

The Current Market Size and Forecast of Genetic Testing Market | Market Research Report, 2013-2023

Genetic Testing Market
The global genetic testing market is projected to grow considerably in the coming years, due to the growing number of test to study multiple genes that may help in managing individual health condition. Additionally, the government initiatives to spread awareness with respect to the advantages of procedure is further expected to drive the growth of the market. The market is categorized into carrier testing, diagnostic testing, new-born screening, predictive & pre-symptomatic testing, prenatal testing, based on types of gene testing.


Among the various types, new born screening held the largest share in 2016, due to the growing number of newborn genetic screening programs, while carrier testing is expected to project the fastest growth in demand during the forecast period.

North America was the largest contributor to the market in 2016. According to the NCBI repository that maintains Genetic Testing Registry(GTR)data from 505 lab participants worldwide, the U.S. leads with 259 labs contributions. Some of the key factors leading to the growth of the market in the region are the presence of large number of academic and research institutes, rising government funding, and availability of technologically advanced products. However, Asia-Pacific is expected to witness the fastest growth in the genetic testing market during the forecast period. The major factors driving the region’s growth include increasing awareness about the advantages of predictive testing, and rise in the adoption of advanced technology for clinical applications.


Genetic Testing Market Segmentation

By Type
·         Carrier Testing
·         Diagnostic Testing
·         New-born Screening
·         Predictive and Pre-Symptomatic Testing
·         Prenatal Testing

By Technology
·         Cytogenetic Testing
·         Molecular Testing
·         Biochemical Testing

By Clinical Indication
·         Alzheimer's Disease
·         Cancer
·         Cystic Fibrosis
·         Sickle Cell Anaemia
·         Duchenne's Muscular Dystrophy
·         Thalassemia
·         Huntington’s Disease
·         Others

Major players in the genetic testing market are Transgenomic, Inc., GE Healthcare, 23 & Me Sequenom, Inc., Abbott Laboratories, Biocartis SA, Illumina Inc., 454 Life Sciences, Bio-Rad Laboratories, Luminex Corporation, Affymetrix Inc., Agilent Technologies Inc., Cephide Inc., Beckman Coulter Inc.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Connect with us: LinkedIn | Twitter | Google + | Facebook

Tuesday, 31 July 2018

Insights into Orthopedic Soft Tissue Repair Market and It’s Growth Outlook by 2023

A soft tissue injury is the damage of ligaments, muscles and tendons of hip, knee, shoulder and elbow joint. A soft tissue injury usually occurs from a strain, sprain and continuous use of a particular part of the body and it can result in swelling, pain, bruising and loss of function. To cure soft tissue injury, the soft tissue repair procedure is used. On any soft tissue injury, Protection Rest Ice Compression Elevation (PRICE) principle should be immediately applied to minimize the soft tissue damage and to reduce inflammation caused by it. One of the methods to diagnose soft tissue damage is magnetic resonance imaging (MRI).


On the basis of surgeries, the global orthopedic soft tissue repair market can be broadly segmented as vaginal prolapse, achilles tendinosis repair, lateral epicondylitis, rotator cuff repair, anterior cruciate ligament and gluteal tendon. On the basis of applications, the global orthopedic soft tissue repair market can be broadly bifurcated as hernia repair, dental, dural repair, skin repair, vaginal sling procedures and breast reconstruction repair.

North America had the largest share in global orthopedic soft tissue repair market in 2014, attributed to the increase in sports injury cases due to high share of sports activity in this region. Developed markets of west are heading towards maturity, and the growth is mainly anticipated from the developing countries of Asia-Pacific region. The growth in disposable income coupled with rising health consciousness among the middle class consumers is one of the major drivers for soft tissue repair market in Asia-Pacific region.


Some of the major competitors of the global orthopedic soft tissue repair market are Lifecell Corporation, Johnson & Johnson Services Inc., Smith & Nephew PLC, C.R Bard Inc., Wright Medical, Covidien PLC, Lifenet Health Inc., American Medical Systems Inc., Arthrex Inc., and Integra Lifesciences Corporation.


About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Connect with us: LinkedIn | Twitter | Google + | Facebook


Monday, 30 July 2018

Digital Therapeutics Market: Industry Insight, Trends, Status and Foresight, 2023

The global digital therapeutics market is witnessing considerable growth due to increasing prevalence of chronic diseases and lifestyle associated diseases, growing geriatric population, need to control healthcare cost, and technological advancement. Moreover, increasing focus on preventive healthcare and increase in venture capital investment are supporting the growth of the market.


Digital therapeutics is health care interferences provided through a smart device to boost healthy behaviors and provide therapeutic effects. It is also known as software-as-a-drug. It is a digital system to treat medical conditions and it is cost effective and have the potential to improve patient engagement and bring substantial change in patient health. It is mainly prescribed to help and mange long term conditions such as insomnia, asthma and diabetes. It is used both in combination with conventional therapeutics and standalone.


Government initiatives to reinforce the development and implementation of digital therapeutics solutions are also fueling the growth of the global digital therapeutics market. These programs are for the self-management and patient education improvement skills to encourage healthy lifestyle of an individual.


The key players operating in the global market are Proteus Digital Health Inc., Omada Health Inc., Welldoc Inc., Livongo Health, Noom Inc., Propeller Health, Canary Health Inc., and Mango Health Inc.


About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)

Connect with us: LinkedIn | Twitter | Google + | Facebook

Friday, 27 July 2018

Tissue Diagnostics Market Emerging by Prevalence of Cancer & Technological Advancements


The global tissue diagnostics market is growing significantly due to increasing prevalence of cancer, and technological advancements in tissue diagnostics.
Increasing prevalence of cancer has fuelled the demand of better diagnostic techniques, which could detect cancer in the earliest stage. According to the WHO, in 2012, there were 14 million new cancer cases and 8.2 million cancer related deaths worldwide.


Some of the factors driving the growth of the global tissue diagnostics market are increasing prevalence of cancer, increasing investment in tissue diagnostics by pharmaceutical companies, rising awareness for cancer, rapidly aging population, technological advancements in tissue diagnostics procedures, and increasing healthcare expenditure. In addition, tissue diagnostic procedures enable medical professionals to detect cancer in early stage; hence, fueling the growth of the market.


Geographically, North America will be leading the global tissue diagnostics market in the coming years due to high prevalence of cancer cases, high healthcare expenditure, and presence of a large number of hospitals and pharmaceutical companies.

Asia-Pacific is the fastest growing region in the global tissue diagnostics market. The major reasons for the fastest growth in the region are aging population, increasing disposable income, and improving healthcare infrastructure. Moreover, the tissue diagnostics marketis growing due to large unexplored tissue diagnostics market and large population base suffering with cancer in the emerging economies, such as India and China, of Asia-Pacific region.


Some of the major players operating in the global tissue diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation, Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE Healthcare, and Siemens Healthcare.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)


Connect with us: LinkedIn | Twitter | Google + | Facebook



Biosurgery Market - What Industry Insiders Tell Us About the Future Forecast 2023


The global biosurgery market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure and growing sports related injuries. Moreover, growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases is supporting the growth of the market.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/biosurgery-market/report-sample

Cancer is a serious health concern across the globe. The increasing prevalence of cancer is driving the growth of the biosurgery market globally. According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of WHO that promotes cancer research, as many as 12.7 million new patients were detected with cancer in 2008 globally and the number is expected to reach 21.4 million by 2030. Further, a total of 8.2 million deaths took place globally due to cancer in 2012, of which 1.6 million deaths were due to lung cancer, while 745,000 deaths were due to liver cancer, and 400,000 deaths were a result of oesophageal cancer.


Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/biosurgery-market

Geographically, North America has been the largest market for biosurgery, owing to increased awareness, established healthcare industry, and easy accessibility to advanced technologies. The U.S. contributed largest revenue to the North American as well as global biosurgery market.

Europe has been the second largest market for biosurgery, where the market is driven by the presence of a large pool of patients with chronic diseases, increasing healthcare expenditure and rapidly developing healthcare infrastructure. Globally, the biosurgery market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing prevalence of chronic diseases, increasing per capita income leading to improving standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about biosurgery products in the region.


Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=biosurgery-market

The key players operating in the global biosurgery market are Baxter International Inc., C.R. Bard, Inc., Medtronic, Inc., Johnson & Johnson, Sanofi Group, B. Braun Melsungen AG, Cryolife, Stryker Corporation and Hemostasis, LLC.


About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com


Connect with us: LinkedIn | Twitter | Google + | Facebook

Thursday, 26 July 2018

Cold Pain Therapy Market – Size, Application, Market share, Global Trends and Forecast to 2023

Cold Pain Therapy Market

The global cold pain therapy market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure and growing awareness about cold pain therapy products. Moreover, increase in innovative product launches, increase in road accidents and sport related injuries across the globe is supporting the growth of the market. Based on product, the OTC based product segment lead the global cold pain therapy market owing to its easy availability over the counter, without any doctor prescription and ease of use.


The popularity of cold pain therapy products is due to presence of several pain relief products in market. These products include creams, gels, ointments, sprays, cold packs, rolls, cooling towels, motorized and non-motorized devices. Based on application, the musculoskeletal disorders segment lead the global market due to increasing cases of arthritis, osteoarthritis, joint pain and back pain across the globe.


Geographically, North America has been the largest market for cold pain therapy, owing to increased awareness, and easy accessibility to advanced technologies including motorized and non-motorized devices.Europe has been the second largest market for cold pain therapy, where the market is driven by the increasing popularity of OTC products, increasing healthcare expenditure, increasing arthritis and osteoarthritis and launch of novel products. In 2015, Germany lead the European cold pain therapy market and it is also expected to grow at the fastest rate in Europe, during forecast period. 

Globally, the cold pain therapy market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing awareness about the various marketed products available over the counter including creams, gels, sprays, and cold packs, which are comparatively cheaper and easy to use. In addition, increasing per capita income leading to enhanced standard of living, increasing disposable income, increase in sports injuries and road accidents cases and growing demand for better quality medical care boosts the market growth in the region. The high preference for topical analgesics over oral pills for pain treatment in Japan and China supports the growth of the market.


The key players operating in the global cold pain therapy market are Johnson & Johnson, Sanofi, 3M Company, Hisamitsu Pharmaceutical Co., Inc., Rohto Pharmaceutical Co., Ltd., Medline Industries, Inc., Beiersdorf AG, Breg, Inc., Össur HF and DJO Finance LLC.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Wednesday, 25 July 2018

Medical Robots Market | Medical Industry Emerging with Robo Technology

Medical Robots Market 

The global medical robots market is growing significantly due to increasing demand for minimally invasive surgeries with the help of robots in the industry.

The advanced research and development facilities and new product developments by the companies are supporting to address the demand for cost effective healthcare in the medical robots industry. Surgical robots reduce the pre and post-operative cost and length of stay in hospital.


Some of the factors driving the growth of medical robots market are rise in geriatric population, increasing prevalence of neurological and orthopedic conditions, rising demand for telemedicine, technological advancement in automation of healthcare industry, and increased demand and usage of robot assisted procedures.

Geographically, North America will be leading the global medical robots market in the coming years, due to rise in aging population, growing prominence of rehabilitation robots, and favourable reimbursement policies.

Asia-Pacific is the fastest growing region in the global medical robots market. The major reasons contributing to the fastest growth in the region are increasing healthcare expenditure, large pool of patients, rise in government support and funding, increasing medical tourism, and improving healthcare infrastructure in the region. Moreover, the medical robots market is also growing due to increasing awareness of patients in the emerging countries, such as India and China, of Asia-Pacific region.


Some of the companies operating in the medical robots market are Accuray, Inc., Titan Medical, Inc., Health Robotics S.R.L., Renishaw Plc., Hansen Medical, Inc., OR Productivity Plc, Mako Surgical Corporation, Swisslog Holding Ltd., Medrobotics Corporation, Intuitive Surgical Inc., ZOLI Medical Corporation, Mckesson Corporation, and Mazor Robotics Ltd.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)


Connect with us: LinkedIn | Twitter | Google + | Facebook